← Open Payments lookup

MELISSA HOEGG: Open Payments

NPI 1205458130 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 36 payments from 15 companies in 2025. Trend: 2023 $520 · 2024 $257 · 2025 $686

Food & beverage: $623Education: $63
CompanyPaymentsAmount
PFIZER INC.15$252
Celgene Corporation4$83
AstraZeneca Pharmaceuticals LP2$61
E.R. Squibb & Sons, L.L.C.2$43
GlaxoSmithKline, LLC.2$42
Gilead Sciences, Inc.2$36
Iovance Biotherapeutics, Inc.1$24
ADC THERAPEUTICS AMERICA, INC.1$21
Aveo Pharmaceuticals, Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: XTANDI, REBLOZYL, IBRANCE, ENHERTU, OPDUALAG, OJJAARA, INLYTA, Trodelvy.

Industry payments across KY — which companies pay providers there.